How to write a good sentence – length and rhythm
By Clare Gurton (clare.gurton@rxcomms.com) A sentence should not only make sense but should also be capable of standing alone as a complete unit; a good sentence will also have shape…
Details
Understanding study design in comparing drug studies
By Robert Hand (robert.hand@rxcomms.com) For a variety of reasons, pharmaceutical manufacturers often do not conduct head-to-head studies of their drugs versus the competition. On the other hand, head-to-head studies are…
Details
The “other drug costs” – Part 1: non-adherence
By Mary Gabb (mary.gabb@rxcomms.com) The term “adherence” (or sometimes “compliance”) – the extent to which patients take their treatment as prescribed – has been understood to be a nagging clinical…
Details
The power of emotional intelligence
By Clare Gurton (clare.gurton@rxcomms.com) When the Harvard Business Review published an article on emotional intelligence several years ago, it attracted a higher percentage of readers than any other article published…
Details
Sorting out the varying standards for pharmacoeconomic guidelines
By Kevin Frick (kevin.frick@rxcomms.com) As we provide and interpret pharmacoeconomic (PE) evaluation results for decision makers in different settings around the world, we should consider the standards being followed. And…
Details
HOC people – David B. Nash, MD, MBA
By David Woods (david.woods@rxcomms.com) US News and World Report calls him a patient safety guru; Modern Healthcare has repeatedly named him among the top 100 most powerful people in American…
Details
Is there a place for healthcare blogs?
By David Woods (david.woods@rxcomms.com) Weblogs, or Blogs, have been around for about a decade. Generally viewed as quirky or even anarchic, they may now be gaining a new respectability and…
Details
Why not take a ‘sensory break?’
By Clare Gurton (clare.gurton@rxcomms.com) During a coffee-break at a recent medical conference, I went outside and almost immediately became aware of the familiar sounds of swifts high above. As I…
Details
HOC people – Diana Brixner
By David Woods (david.woods@rxcomms.com) Newly-installed ISPOR president Diana Brixner, RPh, PhD, has put together a challenging agenda for the society during her term of office. The central point of that…
Details
Simplifying drug labels
By David Woods (david.woods@rxcomms.com) The Institute of Medicine, which made headlines some years ago when it estimated that medical mistakes kill as many as 98,000 patients a year, followed up…
Details